ProfessionalLive Classes

Introduction to Psychedelic-assisted Therapy​​

The Introduction to Psychedelic-assisted Therapy is a continuing education credited training course designed for practising psychologists, psychiatrists, and other medical professionals. The course is a prerequisite for the ATMA Advanced Psychedelic-assisted Therapy (PaT) Certification Program, and

Provider

Atma Journey
English

Details

21 Hours
12 modules
Next cohort: Sep 5, 2024

Enrollment

Upcoming Cohort

Start date: September 5, 2024

Apply now →

Course Overview

The Introduction to Psychedelic-assisted Therapy is a continuing education credited training course designed for practising psychologists, psychiatrists, and other medical professionals. The course is a prerequisite for the ATMA Advanced Psychedelic-assisted Therapy (PaT) Certification Program, and is accepting registrations every second month.

The course begins by redefining the psychiatric model from one of "chemical imbalance" to one rooted in the mind-body-spirit dynamic, and provides historical context for the development of psychedelic medicines. The didactic course material will cover various psychedelic medicines currently in use, including an emphasis on psilocybin, MDMA, LSD, iboga, ayahuasca, and ketamine. The course will also explore how psychedelic-assisted therapy can be integrated into and enhance existing therapeutic modalities, such as internal family systems (IFS), cognitive-behavioural therapy (CBT), somatic therapy, and eye movement desensitization and reprocessing (EMDR).

The program includes 12 lessons, 17 hours of video lectures, 4 hours of interactive Q&A, community platform membership and CE credits (valid in Canada). The training is designed to provide evidence-based tools to enhance current practice for practising social workers, counsellors, psychologists, psychiatrists and medical professionals.

About the Provider

ATMA Journey Centers is an Alberta-based Canadian pioneer in psychedelic-assisted therapy, operating clinically supervised locations across Canada while offering comprehensive psychedelic-assisted therapy training programs (ATMA CENA) covering psilocybin, MDMA, and ketamine for healthcare professionals. With 740+ training alumni and 800+ community members, ATMA also operates a clinic network partnership program and Phase II psilocybin clinical trials with Health Canada approval.

Last verified March 2, 2026

Course Details

  • Price$1,600
  • Format
    Live Classes
  • Level
    Professional
  • Duration21 Hours· 12 modules
  • LanguageEnglish
  • Accreditation
    CE
  • Skills
    evidence-based toolspsychedelic therapymind-body-spirit dynamicpsychiatric modelpsychedelic medicinestherapeutic modalitiesinternal family systemscognitive-behavioral therapysomatic therapyeye movement desensitizationreprocessing
  • Provider
    Atma Journey
Enroll in Course

You will be redirected to the provider's website